Vaccine to Prevent West Nile Virus Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 22, 2005

Study Completion Date

January 15, 2008

Conditions
HealthyWest Nile FeverHealthy VolunteerHV
Interventions
DRUG

VRC-WNVDNA017-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00106769 - Vaccine to Prevent West Nile Virus Disease | Biotech Hunter | Biotech Hunter